Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

Apr 22, 2019

SELL
$216.71 - $338.96 $153,864 - $240,661
-710 Closed
0 $0
Q4 2018

Feb 04, 2019

BUY
$278.5 - $352.75 $197,735 - $250,452
710 New
710 $214,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $32.3B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Community Financial Services Group, LLC Portfolio

Follow Community Financial Services Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Community Financial Services Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Community Financial Services Group, LLC with notifications on news.